The global acne drugs industry size was valued at USD 4.1 billion in 2017 and is anticipated to register a CAGR of 4.2% during the forecast period. The market is projected to exhibit moderate growth over the forecast period, which can be attributed to factors such as emergence of biologics, unhealthy lifestyle, and rising disease incidence.